236 related articles for article (PubMed ID: 23098562)
81. Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration.
Jacobson SG; Sumaroka A; Aleman TS; Cideciyan AV; Schwartz SB; Roman AJ; McInnes RR; Sheffield VC; Stone EM; Swaroop A; Wright AF
Hum Mol Genet; 2004 Sep; 13(17):1893-902. PubMed ID: 15229190
[TBL] [Abstract][Full Text] [Related]
82. Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors.
Chin J; Adams AD; Bouffard A; Green A; Lacson RG; Smith T; Fischer PA; Menke JG; Sparrow CP; Mitnaul LJ
Assay Drug Dev Technol; 2003 Dec; 1(6):777-87. PubMed ID: 15090224
[TBL] [Abstract][Full Text] [Related]
83. A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors.
Xiong C; Baker D; Pietrantonio P
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36533828
[TBL] [Abstract][Full Text] [Related]
84. Development of a Time-Resolved Fluorescence Resonance Energy Transfer ultra-high throughput screening assay for targeting SYK and FCER1G interaction.
Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; ; Fu H
bioRxiv; 2024 Jun; ():. PubMed ID: 38915662
[TBL] [Abstract][Full Text] [Related]
85. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
86. Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells.
Stroik DR; Yuen SL; Janicek KA; Schaaf TM; Li J; Ceholski DK; Hajjar RJ; Cornea RL; Thomas DD
Sci Rep; 2018 Aug; 8(1):12560. PubMed ID: 30135432
[TBL] [Abstract][Full Text] [Related]
87. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
[TBL] [Abstract][Full Text] [Related]
88. A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation.
Maier-Peuschel M; Frölich N; Dees C; Hommers LG; Hoffmann C; Nikolaev VO; Lohse MJ
J Biol Chem; 2010 Mar; 285(12):8793-800. PubMed ID: 20083608
[TBL] [Abstract][Full Text] [Related]
89. The loss of transcriptional inhibition by the photoreceptor-cell specific nuclear receptor (NR2E3) is not a necessary cause of enhanced S-cone syndrome.
Fradot M; Lorentz O; Wurtz JM; Sahel JA; Léveillard T
Mol Vis; 2007 Apr; 13():594-601. PubMed ID: 17438525
[TBL] [Abstract][Full Text] [Related]
90. Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays.
Imbert PE; Unterreiner V; Siebert D; Gubler H; Parker C; Gabriel D
Assay Drug Dev Technol; 2007 Jun; 5(3):363-72. PubMed ID: 17638536
[TBL] [Abstract][Full Text] [Related]
91. A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
Rectenwald JM; Hardy PB; Norris-Drouin JL; Cholensky SH; James LI; Frye SV; Pearce KH
SLAS Discov; 2019 Jul; 24(6):693-700. PubMed ID: 31017815
[TBL] [Abstract][Full Text] [Related]
92. Development of a high-throughput calcium flux assay for identification of all ligand types including positive, negative, and silent allosteric modulators for G protein-coupled receptors.
Noblin DJ; Bertekap RL; Burford NT; Hendricson A; Zhang L; Knox R; Banks M; O'Connell J; Alt A
Assay Drug Dev Technol; 2012 Oct; 10(5):457-67. PubMed ID: 22746835
[TBL] [Abstract][Full Text] [Related]
93. Deregulation of NR2E3, an orphan nuclear receptor, by benzo(a)pyrene-induced oxidative stress is associated with histone modification status change of the estrogen receptor gene promoter.
Khanal T; Kim D; Johnson A; Choubey D; Kim K
Toxicol Lett; 2015 Sep; 237(3):228-36. PubMed ID: 26149760
[TBL] [Abstract][Full Text] [Related]
94. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
[TBL] [Abstract][Full Text] [Related]
95. Development of an HTS-compatible assay for discovery of RORα modulators using AlphaScreen® technology.
Istrate MA; Spicer TP; Wang Y; Bernard JA; Helvering LM; Bocchinfuso WP; Richardson TI; Zink R; Kumar N; Montrose-Rafizadeh C; Dodge J; Hodder P; Griffin PR
J Biomol Screen; 2011 Feb; 16(2):183-91. PubMed ID: 21297105
[TBL] [Abstract][Full Text] [Related]
96. A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands.
Boichenko I; Deiss S; Bär K; Hartmann MD; Hernandez Alvarez B
J Med Chem; 2016 Jan; 59(2):770-4. PubMed ID: 26730808
[TBL] [Abstract][Full Text] [Related]
97. Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist.
Nakagawa H; Koyama R; Kamada Y; Ochida A; Kono M; Shirai J; Yamamoto S; Ambrus-Aikelin G; Sang BC; Nakayama M
Pharmacology; 2018; 102(5-6):244-252. PubMed ID: 30134246
[TBL] [Abstract][Full Text] [Related]
98. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model.
Xu Y; Wang J; Bao Y; Jiang W; Zuo L; Song D; Hong B; Si S
Anal Biochem; 2010 May; 400(2):207-12. PubMed ID: 20152792
[TBL] [Abstract][Full Text] [Related]
99. A Solid Supported Membrane-Based Technology for Electrophysical Screening of B
Gerbeth-Kreul C; Pommereau A; Ruf S; Kane JL; Kuntzweiler T; Hessler G; Engel CK; Shum P; Wei L; Czech J; Licher T
SLAS Discov; 2021 Jul; 26(6):783-797. PubMed ID: 33955247
[TBL] [Abstract][Full Text] [Related]
100. A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.
Rocha-Sousa A; Hayashi T; Gomes NL; Penas S; Brandão E; Rocha P; Urashima M; Yamada H; Tsuneoka H; Falcão-Reis F
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):201-8. PubMed ID: 20725840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
